Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.4.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JF.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JD.1.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.5.1.14SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.7.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KW.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
MF.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LF.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KR.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.7.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LF.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.64SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.44SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.32SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EG.5.1.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
KP.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDK.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KQ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.46SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.48SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.47.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.7.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.8.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
HV.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.4.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.8.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.45SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.4.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDRSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.38SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.43.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.29SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.7.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KV.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBB.1.16.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.39SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JD.1.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used